bpc-157 clinical trial august 2025 Stable Gastric Pentadecapeptide BPC 157 as a Therapy and Safety Key: A Special Beneficial Pleiotropic Effect Controlling and Modulating Angiogenesis and the NO-System BPC 157 Benefits: Heal &

The compound interacts with Gamma-Aminobutyric Acid (GABA) receptors and influences nitric oxide signaling in neural tissue, providing a measurable protective effect against oxidative stress-induced neuronal damage

At SynergenX, we offer B-12 in the form of a Methylcobalamin injection

Do not spray it directly onto the powder, as this can damage the fragile peptide chains

A peptide with asparagine-glycine sequences will deamidate faster

Technical datasheet Identity Physicochemical Handling & storage Compliance What's Included Research-grade vial Lyophilised powder, sealed under inert gas Certificate of Analysis Batch-specific HPLC & MS verification Tamper-evident seal Intact seal confirms product integrity Discreet packaging Plain, unbranded outer packaging COA & Testing Every batch of BPC-157 is independently analysed by HPLC and Mass Spectrometry before dispatch